Company intelligence / Profile preview
Armata Pharmaceuticals
Los Angeles, California, United Statesarmatapharma.com ↗
- Ownership
- Public · ARMP
- Development stage
- Other
01
Overview
Armata has completed three critical Phase 2 trials as of early 2025. Its lead program AP‑PA02 showed encouraging topline results in the Phase 2 Tailwind study for chronic pulmonary Pseudomonas aeruginosa infection in non-cystic fibrosis bronchiectasis patients—demonstrating durable reduction of bacteria with a favorable safety profile. The AP‑SA02 program for S. aureus bacteremia completed enrollment in a Phase 1b/2a trial; topline results are expected soon. Both programs have shown good tolerability at high doses with no significant adverse events reported to date.
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- Bacteriophage therapeutics (natural and synthetic phages)
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
03
Partnerships
U.S. Department of Defense/MTEC (grant funding for clinical trials)Cystic Fibrosis Foundation Therapeutics Development Award ($5M grant support)
04
Financials
- Market cap
- $111.5M
- Total revenue
- $4.9M
- Enterprise value
- $401.5M
Beyond the preview
Go deeper on Armata Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Armata Pharmaceuticals.